{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T05:30:53Z","timestamp":1744349453662,"version":"3.37.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia, IP national support through CHRC \u2013 Comprehensive Health Research Centre","award":["UIDP\/04923\/2020","UIDP\/04923\/2020","UIDP\/04923\/2020"],"award-info":[{"award-number":["UIDP\/04923\/2020","UIDP\/04923\/2020","UIDP\/04923\/2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Educ"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pharmacovigilance stands out for its importance in obtaining existing knowledge about medicine and patient safety and should be recognized as a continuous line of study. It constitutes a highly relevant component in the activities of health professionals, with spontaneous notification of suspected adverse drug reactions being its main emphasis. The underreporting that persists can be overcome through continuous professional development programs, reinforcing theoretical and practical knowledge in the curricular plans of health courses. As a result, more educated professionals will also allow citizens to recognize the importance of pharmacovigilance. The main objective of this study was to describe and characterize the teaching-learning process of pharmacovigilance in Portugal, analyzing the knowledge, perceptions and attitudes of students and health professionals. In total, ninety-three curricular unit forms of the seventeen healthcare courses included were analyzed, among which only three referred to pharmacovigilance as mandatory and thirty-nine did not address any keywords. The questionnaire applied was answered by 650 participants, both students (62%) and professionals (38%). Approximately 84.4% of the students and 54.7% of the professionals affirmed that they had never spontaneously reported an adverse drug reaction. Only 24.6% of the students and 17.8% of professionals referred to the existence of specific course content dedicated to pharmacovigilance in their coursework. In view of these results, it is evident that there is a need for a wider reflection regarding the further training and constant update of practicing professionals as well as in diverse health institutions, investing in the creation of an academic curriculum that integrates pharmacovigilance in healthcare courses.<\/jats:p>","DOI":"10.1186\/s12909-023-04963-1","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T16:03:27Z","timestamp":1704297807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacovigilance teaching and learning: a mixed cross-sectional analysis of the Portuguese public higher education system"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5754-3482","authenticated-orcid":false,"given":"Margarida","family":"Perdig\u00e3o","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5517-4855","authenticated-orcid":false,"given":"Anabela","family":"Afonso","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0749-9137","authenticated-orcid":false,"given":"Sofia","family":"de Oliveira-Martins","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7554-8041","authenticated-orcid":false,"given":"Manuel Jos\u00e9","family":"Lopes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0689-276X","authenticated-orcid":false,"given":"Ana Margarida","family":"Advinha","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"issue":"9","key":"4963_CR1","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.clinthera.2015.07.015","volume":"37","author":"S Soares","year":"2015","unstructured":"Soares S, Roque F, Teixeira Rodrigues A, Figueiras A, Herdeiro MT. Safety alerts: an observational study in Portugal. Clin Ther. 2015;37(9):2122\u20138.","journal-title":"Clin Ther"},{"key":"4963_CR2","first-page":"20","volume":"2","author":"World Health Organization","year":"2002","unstructured":"World Health Organization. Drug Safety of Medicines. World Health Organization Geneva. 2002;2:20.","journal-title":"World Health Organization Geneva"},{"unstructured":"World Health Organization. The Importance of Pharmacovigilance. 2002.","key":"4963_CR3"},{"unstructured":"INFARMED IP. Farmacovigil\u00e2ncia em Portugal 25 anos +. 2018.","key":"4963_CR4"},{"unstructured":"EMA, Module. XVI \u2013 Risk minimisation measures: selection of tools and effectiveness indicators (Rev 2). RegS09 [Internet]. 2017;(February):1\u201347. Available from: http:\/\/www.jfda.jo\/Download\/JPC\/TheGoodPharmacovigilancePracticev2.pdf","key":"4963_CR5"},{"issue":"3","key":"4963_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/pharmacy9030147","volume":"9","author":"A Seselja Perisin","year":"2021","unstructured":"Seselja Perisin A, Bukic J, Rusic D, Leskur D, Bozic J, Mihanovic A, et al. Teaching pharmacovigilance to Healthcare students: identifying gaps and opportunities for Improvement. Pharmacy. 2021;9(3):147.","journal-title":"Pharmacy"},{"issue":"July","key":"4963_CR7","first-page":"14","volume":"50","author":"I Ribeiro-Vaz","year":"2016","unstructured":"Ribeiro-Vaz I, Santos CC, Cruz-Correia R. Promoting adverse drug reaction reporting: comparison of different approaches. Rev Saude Publica. 2016;50(July):14.","journal-title":"Rev Saude Publica"},{"unstructured":"Pernas SI dos, Farmacovigil\u00e2ncia S. As atitudes dos enfermeiros perante a notifica\u00e7\u00e3o. Universidade de Aveiro; 2009.","key":"4963_CR8"},{"doi-asserted-by":"crossref","unstructured":"Batel-Marques F, Mendes D, Alves C, Penedones A, Dias P, Martins A et al. Farmacovigil\u00e2ncia em Portugal: Atividade Da Unidade Regional do Centro Pharmacovigilance in Portugal: activity of the Central Pharmacovigilance Unit. 2015; Available from: www.actamedicaportuguesa.com.","key":"4963_CR9","DOI":"10.20344\/amp.5717"},{"unstructured":"Study designs \u2014 Centre for Evidence-Based Medicine (CEBM)., University of Oxford [Internet]. 2016 [cited 2021 Apr 6]. Available from: https:\/\/www.cebm.ox.ac.uk\/resources\/ebm-tools\/study-designs","key":"4963_CR10"},{"unstructured":"Team SC. Quanticate - The Clinical Data Experts. 2017 [cited 2021 Apr 5]. The Analysis of Direct and Indirect Pathways in Observational Studies. Available from: https:\/\/www.quanticate.com\/blog\/the-analysis-of-direct-and-indirect-pathways-in-observational-studies","key":"4963_CR11"},{"doi-asserted-by":"crossref","unstructured":"Haines HM, Meyer JC, Summers RS, Godman BB. Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district. Eur J Clin Pharmacol [Internet]. 2020;76(7):991\u20131001. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7306046\/","key":"4963_CR12","DOI":"10.1007\/s00228-020-02862-8"},{"doi-asserted-by":"crossref","unstructured":"Othman GQ, Ibrahim MIM, Alshakka M, Ansari M, Al-Qadasi F, Halboup AM. Knowledge and perception about pharmacovigilance among pharmacy students of universities in Sana\u2019a Yemen. Journal of Clinical and Diagnostic Research [Internet]. 2017;11(6):FC09-FC13. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5535384\/","key":"4963_CR13","DOI":"10.7860\/JCDR\/2017\/24228.10028"},{"doi-asserted-by":"crossref","unstructured":"Cheema E, Haseeb A, Khan TM, Sutcliffe P, Singer DR. Barriers to reporting of adverse drugs reactions: A cross sectional study among community pharmacists in United Kingdom. Pharm Pract (Granada) [Internet]. 2017;15(3):1\u20137. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5597805\/pdf\/pharmpract-15-931.pdf","key":"4963_CR14","DOI":"10.18549\/PharmPract.2017.03.931"},{"doi-asserted-by":"crossref","unstructured":"Syed A, Azhar S, Raza M, Saeed H, Jamshed S. Assessment of Knowledge, Attitude and Barriers towards Pharmacovigilance among Physicians and Pharmacists of Abbottabad, Pakistan. Pharmacy [Internet]. 2018;6(2):29. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6025379\/","key":"4963_CR15","DOI":"10.3390\/pharmacy6020029"},{"doi-asserted-by":"publisher","unstructured":"Li R, Curtain C, Bereznicki L, Zaidi STR. Community pharmacists\u2019 knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey. Int J Clin Pharm [Internet]. 2018;40(4):878\u201389. https:\/\/doi.org\/10.1007\/s11096-018-0700-2","key":"4963_CR16","DOI":"10.1007\/s11096-018-0700-2"},{"doi-asserted-by":"publisher","unstructured":"Zin RM, Hong YH, Ming LC, Khan TM, Dali AF, Neoh CF. Survey of knowledge, attitudes and practice regarding adverse drug reaction (ADR) reporting among community pharmacists in Selangor, Malaysia. Journal of Pharmacy Practice and Research [Internet]. 2019;49(3):234\u20139. https:\/\/doi.org\/10.1002\/jppr.1495","key":"4963_CR17","DOI":"10.1002\/jppr.1495"},{"doi-asserted-by":"crossref","unstructured":"Ali MD, Ahmad A, Hassan YAM, Ghosn SA, Banu N, Alzahrani MG. Community Pharmacist\u2019s Knowledge, Practice and Barrier towards Reporting of Adverse Drug Reactions in Dammam, Saudi Arabia: A Cross-Sectional Survey Based Study. Journal of Young Pharmacists [Internet]. 2020;12(1):81\u20135. Available from: https:\/\/www.jyoungpharm.org\/sites\/default\/files\/JYoungPharm-12-1-81-85_0.pdf","key":"4963_CR18","DOI":"10.5530\/jyp.2020.12.16"},{"issue":"1","key":"4963_CR19","first-page":"131","volume":"12","author":"MS Srikanth","year":"2019","unstructured":"Srikanth MS, Adepu R. Assessment of structured educational intervention and barriers of community pharmacists towards adverse drug reaction reporting and monitoring in south Indian district. Drug Invention Today. 2019;12(1):131\u201341.","journal-title":"Drug Invention Today"},{"unstructured":"Rep\u00fablica Portuguesa. Dados e Estat\u00edsticas de Cursos Superiores - Base de Dados julho 2021 [Internet]. 2021 [cited 2023 Nov 6]. Available from: https:\/\/infocursos.medu.pt\/bds.asp","key":"4963_CR20"},{"unstructured":"Minist\u00e9rio da Sa\u00fade e Servi\u00e7o Nacional da Sa\u00fade. RELAT\u00d3RIO, SOCIAL DO MINIST\u00c9RIO DA SA\u00daDE E DO SERVI\u00c7O NACIONAL. DE SA\u00daDE \u2013\u20092018 [Internet]. 2019 [cited 2023 Nov 6]. p.\u00a039. Available from: https:\/\/www.acss.min-saude.pt\/wp-content\/uploads\/2019\/09\/Relatorio-Social-MS_SNS_2018_vf.pdf","key":"4963_CR21"},{"issue":"4","key":"4963_CR22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4103\/0253-7613.161272","volume":"47","author":"MA Arici","year":"2015","unstructured":"Arici MA, Gelal A, Demiral Y, Tuncok Y. Short and long-term impact of pharmacovigilance training on the pharmacovigilance knowledge of medical students. Indian J Pharmacol. 2015;47(4):436\u20139.","journal-title":"Indian J Pharmacol"},{"doi-asserted-by":"crossref","unstructured":"Hussain R, Hassali MA, Hashmi F, Akram T. Exploring healthcare professionals\u2019 knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey. J Pharm Policy Pract. 2021;14(1).","key":"4963_CR23","DOI":"10.1186\/s40545-020-00287-3"},{"issue":"9","key":"4963_CR24","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00228-019-02702-4","volume":"75","author":"PB Patel","year":"2019","unstructured":"Patel PB, Patel TK. Mortality among patients due to adverse drug reactions that occur following hospitalisation: a meta-analysis. Eur J Clin Pharmacol. 2019;75(9):1293\u2013307.","journal-title":"Eur J Clin Pharmacol"},{"doi-asserted-by":"publisher","unstructured":"Rocca E, Copeland S, Ralph Edwards I. Pharmacovigilance as Scientific Discovery: An Argument for Trans-Disciplinarity. Drug Saf [Internet]. 2019;42(10):1115\u201324. https:\/\/doi.org\/10.1007\/s40264-019-00826-1","key":"4963_CR25","DOI":"10.1007\/s40264-019-00826-1"},{"issue":"1","key":"4963_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-017-2586-9","volume":"10","author":"KP Osemene","year":"2017","unstructured":"Osemene KP, Afolabi MO. An evaluation of the knowledge and perceptions of pharmacy students on pharmacovigilance activities in Nigeria. BMC Res Notes. 2017;10(1):1\u201310.","journal-title":"BMC Res Notes"},{"issue":"5","key":"4963_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/bcpt.13170","volume":"124","author":"YM Yu","year":"2019","unstructured":"Yu YM, Kim S, Choi KH, Jeong KH, Lee E. Impact of knowledge, attitude and preceptor behaviour in pharmacovigilance education. Basic Clin Pharmacol Toxicol. 2019;124(5):591\u20139.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"4963_CR28","first-page":"91","volume":"6","author":"MA Hadi","year":"2017","unstructured":"Hadi MA, Neoh CF, Zin RM, Elrggal M, Cheema E. Pharmacovigilance: pharmacists\u2019 perspective on spontaneous adverse drug reaction reporting. Integr Pharm Res Pract. 2017;6:91\u20138.","journal-title":"Integr Pharm Res Pract"},{"doi-asserted-by":"crossref","unstructured":"Elkalmi RM, Hassali MA, Ibrahim MIM, Widodo RT, Efan QMA, Hadi MA. Pharmacy students\u2019 knowledge and perceptions about pharmacovigilance in Malaysian public universities. Am J Pharm Educ. 2011;75(5).","key":"4963_CR29","DOI":"10.5688\/ajpe75596"},{"doi-asserted-by":"publisher","unstructured":"Rajiah K, Maharajan MK, Nair S. Pharmacy students\u2019 knowledge and perceptions about adverse drug reactions reporting and pharmacovigilance. Saudi Pharmaceutical Journal [Internet]. 2016;24(5):600\u20134. https:\/\/doi.org\/10.1016\/j.jsps.2015.03.021","key":"4963_CR30","DOI":"10.1016\/j.jsps.2015.03.021"},{"issue":"10","key":"4963_CR31","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00228-018-2500-y","volume":"74","author":"M Reumerman","year":"2018","unstructured":"Reumerman M, Tichelaar J, Piersma B, Richir MC, van Agtmael MA. Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature. Eur J Clin Pharmacol. 2018;74(10):1235\u201348.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"4963_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s40264-016-0502-1","volume":"40","author":"T Schutte","year":"2017","unstructured":"Schutte T, Tichelaar J, Reumerman MO, van Eekeren R, Rolfes L, van Puijenbroek EP, et al. Feasibility and Educational Value of a Student-Run Pharmacovigilance Programme: a prospective cohort study. Drug Saf. 2017;40(5):409\u201318.","journal-title":"Drug Saf"},{"unstructured":"Kirsch V, Johannsen W, Thrien C, Herzig S, Matthes J. Hopefully, i will never forget that again - sensitizing medical students for drug safety by working on cases and simulating doctor-patient communication. GMS J Med Educ [Internet]. 2019;36(2):1\u201317. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6446464\/pdf\/JME-36-2-17.pdf","key":"4963_CR33"},{"doi-asserted-by":"crossref","unstructured":"Assiri GA, Shebl NA, Mahmoud MA, Aloudah N, Grant E, Aljadhey H et al. What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature. BMJ Open. 2018;8(5).","key":"4963_CR34","DOI":"10.1136\/bmjopen-2017-019101"},{"issue":"7","key":"4963_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/0253-7613.193314","volume":"48","author":"R Tripathi","year":"2016","unstructured":"Tripathi R, Jalgaonkar S, Sarkate P, Rege N. Implementation of a module to promote competency in adverse drug reaction reporting in undergraduate medical students. Indian J Pharmacol. 2016;48(7):69\u201373.","journal-title":"Indian J Pharmacol"},{"doi-asserted-by":"crossref","unstructured":"Reumerman M, Tichelaar J, Richir MC, van Agtmael MA. Medical students as adverse drug event managers, learning about side effects while improving their reporting in clinical practice. Naunyn Schmiedebergs Arch Pharmacol. 2021.","key":"4963_CR36","DOI":"10.1007\/s00210-021-02060-y"},{"issue":"2","key":"4963_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/jonm.12310","volume":"24","author":"A De Angelis","year":"2016","unstructured":"De Angelis A, Colaceci S, Giusti A, Vellone E, Alvaro R. Factors that condition the spontaneous reporting of adverse drug reactions among nurses: an integrative review. J Nurs Manag. 2016;24(2):151\u201363.","journal-title":"J Nurs Manag"},{"issue":"11","key":"4963_CR38","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00228-017-2309-0","volume":"73","author":"C Bigi","year":"2017","unstructured":"Bigi C, Bocci G. The key role of clinical and community health nurses in pharmacovigilance. Eur J Clin Pharmacol. 2017;73(11):1379\u201387.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"4963_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00210-017-1430-z","volume":"391","author":"T Schutte","year":"2018","unstructured":"Schutte T, van Eekeren R, Richir M, van Staveren J, van Puijenbroek E, Tichelaar J, et al. The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study. Naunyn Schmiedebergs Arch Pharmacol. 2018;391(1):17\u201326.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"7","key":"4963_CR40","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00228-017-2237-z","volume":"73","author":"J Hartman","year":"2017","unstructured":"Hartman J, H\u00e4rmark L, van Puijenbroek E. A global view of undergraduate education in pharmacovigilance. Eur J Clin Pharmacol. 2017;73(7):891\u20139.","journal-title":"Eur J Clin Pharmacol"},{"doi-asserted-by":"crossref","unstructured":"Herrera Comoglio R. Undergraduate and postgraduate pharmacovigilance education: A proposal for appropriate curriculum content. Br J Clin Pharmacol [Internet]. 2020;86(4):779\u201390. Available from: https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/full\/10.1111\/bcp.14179","key":"4963_CR41","DOI":"10.1111\/bcp.14179"},{"unstructured":"Document I. SCOPE Work Package 6 Risk Communication Proposals for SCOPE Work Package 6 Risk Communication \u2013. 2016;(March).","key":"4963_CR42"},{"issue":"6","key":"4963_CR43","first-page":"259","volume":"9","author":"RL Soiza","year":"2018","unstructured":"Soiza RL, Donaldson AIC, Myint PK. Vaccine against arteriosclerosis: an update. Ther Adv Vaccines. 2018;9(6):259\u201361.","journal-title":"Ther Adv Vaccines"},{"doi-asserted-by":"publisher","unstructured":"Lawson R, G\u00e9niaux H, Bailly S, Pouget C, Fagn\u00e8re C, Laroche ML et al. Contributions of a blended learning based on peer evaluation for teaching drug-drug interactions to undergraduate pharmacy students. BMC Med Educ [Internet]. 2019;19(1):1\u20138. Available from: https:\/\/bmcmededuc.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12909-019-1867-5","key":"4963_CR44","DOI":"10.1186\/s12909-019-1867-5"},{"issue":"2","key":"4963_CR45","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/AOG.0b013e3181b0c0b8","volume":"114","author":"JR Vandenbroucke; Scott","year":"2009","unstructured":"Vandenbroucke; Scott JR. Defense of case reports. Obstet Gynecol. 2009;114(2):413\u20134. PART 2 SUPPL.).","journal-title":"Obstet Gynecol"},{"doi-asserted-by":"crossref","unstructured":"Kaeding M, Schm\u00e4lter J, Klika C. Pharmacovigilance in the European Union. Springer; 2017.","key":"4963_CR46","DOI":"10.1007\/978-3-658-17276-3"},{"doi-asserted-by":"publisher","unstructured":"Abu Farha R, Abu Hammour K, Rizik M, Aljanabi R, Alsakran L. Effect of educational intervention on healthcare providers knowledge and perception towards pharmacovigilance: A tertiary teaching hospital experience. Saudi Pharmaceutical Journal [Internet]. 2018;26(5):611\u20136. https:\/\/doi.org\/10.1016\/j.jsps.2018.03.002","key":"4963_CR47","DOI":"10.1016\/j.jsps.2018.03.002"},{"issue":"5","key":"4963_CR48","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/inthealth\/ihy029","volume":"10","author":"WA Shroukh","year":"2018","unstructured":"Shroukh WA, Shakhatreh FM, Yasein NA, Sharkas GF. A survey on the knowledge, attitudes and practices of physicians towards pharmacovigilance in Jordanian health centres. Int Health. 2018;10(5):363\u201370.","journal-title":"Int Health"},{"doi-asserted-by":"publisher","unstructured":"May F. Teaching and Learning Pharmacovigilance. In: Mann\u2019s Pharmacovigilance: Third Edition [Internet]. Wiley Blackwell; 2014 [cited 2021 Jun 25]. p.\u00a0793\u2013804. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/https:\/\/doi.org\/10.1002\/9781118820186.ch51","key":"4963_CR49","DOI":"10.1002\/9781118820186.ch51"},{"key":"4963_CR50","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2147\/TCRM.S140674","volume":"13","author":"YM Al-Worafi","year":"2017","unstructured":"Al-Worafi YM, Kassab YW, Alseragi WM, Almutairi MS, Ahmed A, Ming LC, et al. Pharmacovigilance and adverse drug reaction reporting: a perspective of community pharmacists and pharmacy technicians in Sana\u2019a, Yemen. Ther Clin Risk Manag. 2017;13:1175\u201381.","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"4963_CR51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/bcpt.13325","volume":"126","author":"BA Adenuga","year":"2020","unstructured":"Adenuga BA, Kibuule D, Rennie TW. Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia. Basic Clin Pharmacol Toxicol. 2020;126(3):247\u201353.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"4963_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.6061\/clinics\/2017(01)09","volume":"72","author":"FR Varallo","year":"2017","unstructured":"Varallo FR, Planeta CS, de Carvalho Mastroianni P. Effectiveness of pharmacovigilance: multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff. Clinics. 2017;72(1):51\u20137.","journal-title":"Clinics"},{"issue":"5","key":"4963_CR53","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/bcpt.12712","volume":"120","author":"T Schutte","year":"2017","unstructured":"Schutte T, Tichelaar J, Reumerman MO, van Eekeren R, Rissmann R, Kramers C, et al. Pharmacovigilance skills, knowledge and attitudes in our future doctors \u2013 A nationwide study in the Netherlands. Basic Clin Pharmacol Toxicol. 2017;120(5):475\u201381.","journal-title":"Basic Clin Pharmacol Toxicol"}],"container-title":["BMC Medical Education"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12909-023-04963-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12909-023-04963-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12909-023-04963-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T16:05:44Z","timestamp":1704297944000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmededuc.biomedcentral.com\/articles\/10.1186\/s12909-023-04963-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4963"],"URL":"https:\/\/doi.org\/10.1186\/s12909-023-04963-1","relation":{},"ISSN":["1472-6920"],"issn-type":[{"type":"electronic","value":"1472-6920"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"9 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of the University of \u00c9vora (ID: 21,028). Informed consent was obtained from all the study participants. The participation of all respondents was voluntary and informed. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13"}}